CAV2 and neoplasm: To examine which immune cell type(s) may increase earlier and consequently initiate the tumor rejection cascade in Cav-2 KO mice we have used the earliest palpable tumors extracted at day 5 after s.c. implantation of LLC but we were unable to recover cell numbers sufficient for reliable flow cytometric analysis.